Evidence map›Paper›PMID 35662331›Full record

ArticleHuman brain mapping2022

Default Mode Network quantitative diffusion and resting-state functional magnetic resonance imaging correlates in sporadic Creutzfeldt-Jakob disease.

Matteo Paoletti, Eduardo Caverzasi, Maria Luisa Mandelli, Jesse A Brown, Roland G Henry, Bruce L Miller, Howard J Rosen, Stephen J DeArmond, Stefano Bastianello, William W Seeley and 1 more

Open access · goldAbstract read
In one paragraph

Article in Human brain mapping, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. PrPStem cell reports · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. PRNP expression predicts imaging findings in sporadic Creutzfeldt-Jakob disease.Annals of clinical and translational neurology · 2023
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 3 countries.

Matteo PaolettiMemory and Aging Center, Department of Neurology, Weill Institute for Neuroscience, University of California San Francisco, San Francisco, California, USA.ORCID 0000-0002-1221-7747
Eduardo CaverzasiWeill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, California, USA.ORCID 0000-0002-0350-0460
Maria Luisa MandelliMemory and Aging Center, Department of Neurology, Weill Institute for Neuroscience, University of California San Francisco, San Francisco, California, USA.ORCID 0000-0002-2518-2520
Jesse A BrownMemory and Aging Center, Department of Neurology, Weill Institute for Neuroscience, University of California San Francisco, San Francisco, California, USA.ORCID 0000-0002-3139-9451
Roland G HenryWeill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, California, USA.ORCID 0000-0002-8232-7562
Bruce L MillerMemory and Aging Center, Department of Neurology, Weill Institute for Neuroscience, University of California San Francisco, San Francisco, California, USA.ORCID 0000-0002-2152-4220
Howard J RosenMemory and Aging Center, Department of Neurology, Weill Institute for Neuroscience, University of California San Francisco, San Francisco, California, USA.ORCID 0000-0001-9281-7402
Stephen J DeArmondDepartment of Pathology, University of California, San Francisco, California, USA.
Stefano BastianelloDepartment of Neuroradiology, IRCCS Mondino Foundation, Pavia, Italy.
William W SeeleyMemory and Aging Center, Department of Neurology, Weill Institute for Neuroscience, University of California San Francisco, San Francisco, California, USA.ORCID 0000-0003-1410-2027
Michael D GeschwindMemory and Aging Center, Department of Neurology, Weill Institute for Neuroscience, University of California San Francisco, San Francisco, California, USA.ORCID 0000-0003-2861-3776
University of California, San Francisco · USUniversity of Pavia · IT

Funding

UCSF CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTEUL1RR024131 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JOHNSTON, S. CLAIBORNE · 2006 to 2011
$111.2M
Engaging University of California Stakeholders for Biorespository ResearchUL1TR000004 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GRANDIS, JENNIFER RUBIN · 2012 to 2015
$78.0M
Research Education ComponentP30AG062422 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HOWARD J ROSEN · 2019 to 2026
$36.9M
Mechanisms of Executive Decline in Normal AgingR01AG032289 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Kaitlin B Casaletto, JOEL H KRAMER · 2009 to 2026
$8.3M
Predicting progression of human prion diseaseR01AG031189 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GESCHWIND, MICHAEL D · 2008 to 2017
$5.7M
Tracking longitudinal change in presymptomatic genetic prion disease (TLC-Pre-gPrD)R01AG062562 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GESCHWIND, MICHAEL D · 2019 to 2023
$5.4M
Biological Predictors Of Brain Aging Trajectories Diversity Supplement: African American Outreach And The Intersection Between Social Determinants Of Health And Biomarkers Of Degenerative DiseaseRF1AG032289 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KRAMER, JOEL H · 2020 to 2021
$5.3M
TLC-Pre-gPrD: Tracking Longitudinal Change in Presymptomatic genetic Prion DiseaseR56AG055619 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GESCHWIND, MICHAEL D · 2018 to 2018
$800k
Amyloid PET in AD, FTLD & PPA: Diagnosis, Functional & Structural CorrelationsK23AG031861 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI RABINOVICI, GIL DAN · 2008 to 2012
$793k
NCATS NIH HHS UL1 TR000004NCRR NIH HHS UL1 RR024131NIA NIH HHS K23 AG031861NIA NIH HHS L30 AG024892NIA NIH HHS P30 AG062422NIA NIH HHS R01 AG031189NIA NIH HHS R01 AG032289NIA NIH HHS R01 AG062562NIA NIH HHS R56 AG055619NIA NIH HHS RF1 AG032289
6 · The paper itself

Abstract

Grey matter involvement is a well-known feature in sporadic Creutzfeldt-Jakob disease (sCJD), yet precise anatomy-based quantification of reduced diffusivity is still not fully understood. Default Mode Network (DMN) areas have been recently demonstrated as selectively involved in sCJD, and functional connectivity has never been investigated in prion diseases. We analyzed the grey matter involvement using a quantitatively multi-parametric MRI approach. Specifically, grey matter mean diffusivity of 37 subjects with sCJD was compared with that of 30 age-matched healthy controls with a group-wise approach. Differences in mean diffusivity were also examined between the cortical (MM(V)1, MM(V)2C, and VV1) and subcortical (VV2 and MV2K) subgroups of sCJD for those with autopsy data available (n = 27, 73%). We also assessed resting-state functional connectivity of both ventral and dorsal components of DMN in a subset of subject with a rs-fMRI dataset available (n = 17). Decreased diffusivity was predominantly present in posterior cortical regions of the DMN, but also outside of the DMN in temporal areas and in a few limbic and frontal areas, in addition to extensive deep nuclei involvement. Both subcortical and cortical sCJD subgroups showed decreased diffusivity subcortically, whereas only the cortical type expressed significantly decreased diffusivity cortically, mainly in parietal, occipital, and medial-inferior temporal cortices bilaterally. Interestingly, we found abnormally increased connectivity in both dorsal and ventral components of the DMN in sCJD subjects compared with healthy controls. The significance and possible utility of functional imaging as a biomarker for tracking disease progression in prion disease needs to be explored further.

Indexed as

Creutzfeldt-Jakob SyndromeBrainDefault Mode NetworkDiffusion Magnetic Resonance ImagingHumansMagnetic Resonance ImagingCJDDMNfMRIMDmean diffusivityMRIresting-statesporadic Jakob-Creutzfeldt disease

Identifiers

PMID35662331
PMCPMC9374887
OpenAlexW4281719095

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.